Pharmaceutical Combination comprising the compound 2 - {2 - [(2S) - 2 - methyl - 1H indole 2,3 dihydro - 1 - yl] - 2-oxoethyl) - 6 - (morpholin-4-yl pyrimidin-2-yl) - 4 - (3H) - one and at least one Pathway inhibitor Pharmaceutical Composition of MAPK; pharmacist; kit; its use in The Treatment of cancer.
The present invention relates to compositions comprising at least one MAPK pathway inhibitor including MEK and RAF inhibitors and at least one PI3K² inhibitor, and also to uses thereof for the treatment of cancer.COMBINACIÓN FARMACÉUTICA QUE COMPRENDE 2-{2-[(2S)-2-METIL-2,3-DIHIDRO-1H-INDOL-1-IL]-2-OXOETIL}-6-(MORFOLIN-4-IL)PIRIMIDIN-4-(3H)-ONA O UNA SAL DEL MISMO Y AL MENOS UN INHIBIDOR DE LA VÍA DE MAPK O UNA SAL DEL MISMO; COMPOSICIÓN FARMACÉUTICA; KIT; USO EN EL TRATAMIENTO DEL CÁNCER.